Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

High concentrations of nonesterified fatty acids (NEFA) are a risk factor for developing type 2 diabetes in Pima Indians. In vitro and in vivo, chronic elevation of NEFA decreases glucose-stimulated insulin secretion. We hypothesized that high fasting plasma NEFA would increase the risk of type 2 diabetes by inducing a worsening of glucose-stimulated insulin secretion in Pima Indians. To test this hypothesis, fasting plasma NEFA concentrations, body composition, insulin action (M), acute insulin response (AIR, 25-g IVGTT), and glucose tolerance (75-g OGTT) were measured in 151 Pima Indians [107 normal glucose tolerant (NGT), 44 impaired glucose tolerant (IGT)] at the initial visit. These subjects, participants in ongoing studies of the pathogenesis of obesity and type 2 diabetes, had follow-up measurements of body composition, glucose tolerance, M, and AIR. In NGT individuals, cross-sectionally, high fasting plasma NEFA concentrations at the initial visit were negatively associated with AIR after adjustment for age, sex, percent body fat, and M (P = 0.03). Longitudinally, high fasting plasma NEFA concentrations at the initial visit were not associated with change in AIR. In individuals with IGT, cross-sectionally, high fasting plasma NEFA concentrations at the initial visit were not associated with AIR. Longitudinally, high fasting plasma NEFA concentrations at the initial visit were associated with a decrease in AIR before (P < 0.0001) and after adjustment for sex, age at follow-up, time of follow-up, change in percent body fat and insulin sensitivity, and AIR at the initial visit (P = 0.0006). In conclusion, findings in people with NGT indicate that fasting plasma NEFA concentrations are not a primary etiologic factor for beta-cell failure. However, in subjects who have progressed to a state of IGT, chronically elevated NEFA seem to have a deleterious effect on insulin-secretory capacity.

[1]  G. Paolisso,et al.  Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects , 1995, Diabetologia.

[2]  E. Ravussin,et al.  A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM , 1995, Diabetologia.

[3]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[4]  M. Prentki,et al.  Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. , 2002, Diabetes.

[5]  G. Lewis,et al.  Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans , 2001, Diabetologia.

[6]  R. Pratley,et al.  The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus , 2001, Diabetologia.

[7]  C. Bogardus,et al.  Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. , 2001, Diabetes.

[8]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[9]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[10]  R. Bergman,et al.  Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. , 1999, American journal of physiology. Endocrinology and metabolism.

[11]  J. McGarry,et al.  Fatty acids, lipotoxicity and insulin secretion , 1999, Diabetologia.

[12]  G. Boden,et al.  Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. , 1998, Diabetes.

[13]  J. McGarry,et al.  Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. , 1998, Diabetes.

[14]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[15]  J. McGarry,et al.  Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. , 1998, The Journal of clinical investigation.

[16]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[17]  E. Ravussin,et al.  Use of dual-energy X-ray absorptiometry in obese individuals. , 1995, The American journal of clinical nutrition.

[18]  G. Boden,et al.  Effects of a 48-h Fat Infusion on Insulin Secretion and Glucose Utilization , 1995, Diabetes.

[19]  R. Unger.  Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.

[20]  J. H. Johnson,et al.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. J. Randle,et al.  Glucose fatty acid interactions and the regulation of glucose disposal , 1994, Journal of cellular biochemistry.

[22]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[23]  W. Siri.  Body composition from fluid spaces and density: analysis of methods. 1961. , 1993, Nutrition.

[24]  M. Elks.  Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. , 1993, Endocrinology.

[25]  V. Grill,et al.  A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. , 1990, Endocrinology.

[26]  R B Mazess,et al.  Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. , 1990, The American journal of clinical nutrition.

[27]  P. Albert,et al.  Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.

[28]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[29]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.

[30]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[31]  S A BERSON,et al.  Immunoassay of endogenous plasma insulin in man. , 1996, The Journal of clinical investigation.

[32]  S. Berson,et al.  Immunoassay of Endogenous Plasma Insulin in Man , 1960 .